LI-COR Biotech: Odyssey M Chemi/Fluor Imaging Bundle Standard

The National Cancer Institute's Laboratory of Human Carcinogenesis is seeking to acquire a new imaging system to replace its outdated protein imager, which is essential for current and future intramural research projects. The required system, identified as the Odyssey M, is designed to serve multiple research applications including fluorescent and colorimetric Western blots, various forms of immunocytochemistry, ELISAs, protein and nucleic acid arrays, high-resolution tissue section analysis, gel detection, nucleic acid detection, and electrophoretic mobility shift assays. The contract opportunity, titled "LI-COR Biotech: Odyssey M Chemi/Fluor Imaging Bundle Standard" with solicitation number 75N91026Q00014, has a response deadline set for June 9, 2026. The procurement is managed by the Department of Health and Human Services, specifically through the Asa Office Of The Assistant Secretary For Administration, with performance expected in Bethesda, Maryland. Key points of contact include Shayna Simpson and Rashiid Cummins. This imaging system is expected to streamline workflows across the lab and division, enhancing the efficiency and capabilities of a wide array of molecular biology and biochemical assays critical to cancer research.